Here we focused on identifying cellular biochemical changes associated with GBA mutations that might predispose to neurodegeneration using fibroblasts generated from a series of patients with Gaucher disease and heterozygous GBA mutation carriers with and without Parkinson’s disease. Here, GBA1 is linked to Gaucher disease.